Literature DB >> 24326415

Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis.

Maria Hemming1, Timo Vesikari.   

Abstract

We describe a case of acute gastroenteritis in a schoolgirl associated with a detection of vaccine-derived, human-bovine double reassortant G1P[8] rotavirus, without any known contact with recently vaccinated infants. We propose that human-bovine double reassortant G1P[8] may be formed in RotaTeq-vaccinated infants and can occasionally cause gastroenteritis symptoms in vaccine recipients who may rarely transmit the virus to close contacts. The present case suggests that such viruses can remain stable in environment longer than 1 transmission cycle.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24326415     DOI: 10.1097/INF.0000000000000221

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model.

Authors:  Miaoge Xue; Linqi Yu; Lianzhi Jia; Yijian Li; Yuanjun Zeng; Tingdong Li; Shengxiang Ge; Ningshao Xia
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

Review 2.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

3.  An infant with acute gastroenteritis caused by a secondary infection with a Rotarix-derived strain.

Authors:  Naomi Sakon; Ryohei Miyamoto; Jun Komano
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

4.  Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Authors:  David O Matson; Timo Vesikari; Penelope Dennehy; Michael D Dallas; Michelle G Goveia; Robbin F Itzler; Max Ciarlet
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Yasutaka Hoshino; Lijuan Yuan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Detection and Clinical Implications of Monovalent Rotavirus Vaccine-Derived Virus Strains in Children with Gastroenteritis in Alberta, Canada.

Authors:  Ran Zhuo; Gillian A M Tarr; Jianling Xie; Stephen B Freedman; Daniel C Payne; Bonita E Lee; Charlotte McWilliams; Linda Chui; Samina Ali; Xiaoli Pang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

Review 7.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

8.  Analysis of human rotaviruses from a single location over an 18-year time span suggests that protein coadaption influences gene constellations.

Authors:  Shu Zhang; Paul W McDonald; Travis A Thompson; Allison F Dennis; Asmik Akopov; Ewen F Kirkness; John T Patton; Sarah M McDonald
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

Review 9.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

10.  Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013.

Authors:  Michael D Bowen; Slavica Mijatovic-Rustempasic; Mathew D Esona; Elizabeth N Teel; Rashi Gautam; Michele Sturgeon; Parvin H Azimi; Carol J Baker; David I Bernstein; Julie A Boom; James Chappell; Stephanie Donauer; Kathryn M Edwards; Janet A Englund; Natasha B Halasa; Christopher J Harrison; Samantha H Johnston; Eileen J Klein; Monica M McNeal; Mary E Moffatt; Marcia A Rench; Leila C Sahni; Rangaraj Selvarangan; Mary A Staat; Peter G Szilagyi; Geoffrey A Weinberg; Mary E Wikswo; Umesh D Parashar; Daniel C Payne
Journal:  J Infect Dis       Date:  2016-06-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.